Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JYSB1300244	谷赖胰岛素注射液	insulin glulisine	Injection	Biological Products	Supplementary Application	2013-10-28	Sanofi-Aventis Deutschland GmbH	Sanofi-Aventis Deutschland GmbH	Certificate Issued	2015-01-22	view
JYSB2000323	谷赖胰岛素注射液	insulin glulisine	Injection	Biological Products	Supplementary Application	2020-06-29	Sanofi-Aventis Deutschland GmbH	Sanofi-Aventis Deutschland GmbH	Filed	2020-07-01	view
JXSS0900003	谷赖胰岛素注射液	insulin glulisine	Injection	Biological Products	Import Drug Application	2009-02-06	Sanofi-Aventis Deutschland GmbH	Sanofi-Aventis Deutschland GmbH	Certificate Issued	2010-03-11	view
JYSB1700216	谷赖胰岛素注射液	insulin glulisine	Injection	Biological Products	Supplementary Application	2017-12-01	Sanofi-Aventis Deutschland GmbH	Sanofi-Aventis Deutschland GmbH	Certificate Issued	2019-04-25	view
JYSB2100068	谷赖胰岛素注射液	insulin glulisine	Injection	Biological Products	Supplementary Application	2021-03-10	Sanofi-Aventis Deutschland GmbH	Sanofi-Aventis Deutschland GmbH	In Review	2021-03-10	view
JYSZ1900022	谷赖胰岛素注射液	insulin glulisine	Injection	Biological Products	License Renew	2019-05-20	Sanofi-Aventis Deutschland GmbH	Sanofi-Aventis Deutschland GmbH	Certificate Issued	2019-10-28	view
JYSB1400045	谷赖胰岛素注射液	insulin glulisine	Injection	Biological Products	Supplementary Application	2014-03-18	Sanofi-Aventis Deutschland GmbH	Sanofi-Aventis Deutschland GmbH	Certificate Issued	2014-08-27	view
JXSL0900002	谷赖胰岛素注射液	insulin glulisine	Injection	Biological Products	Import Drug Application	2009-03-26	Sanofi-Aventis Deutschland GmbH	Sanofi-Aventis Deutschland GmbH	Certificate Issued	2009-12-29	view
JYSB2000322	谷赖胰岛素注射液	insulin glulisine	Injection	Biological Products	Supplementary Application	2020-06-29	Sanofi-Aventis Deutschland GmbH	Sanofi-Aventis Deutschland GmbH	Filed	2020-07-01	view
JXSS0900004	谷赖胰岛素注射液	insulin glulisine	Injection	Biological Products	Import Drug Application	2009-02-06	Sanofi-Aventis Deutschland GmbH	Sanofi-Aventis Deutschland GmbH	Certificate Issued	2010-03-11	view
JYSB2100067	谷赖胰岛素注射液	insulin glulisine	Injection	Biological Products	Supplementary Application	2021-03-10	Sanofi-Aventis Deutschland GmbH	Sanofi-Aventis Deutschland GmbH	In Review	2021-03-10	view
JYSZ1900020	谷赖胰岛素注射液	insulin glulisine	Injection	Biological Products	License Renew	2019-05-20	Sanofi-Aventis Deutschland GmbH	Sanofi-Aventis Deutschland GmbH	Certificate Issued	2019-10-28	view
JYSB1300247	谷赖胰岛素注射液	insulin glulisine	Injection	Biological Products	Supplementary Application	2013-10-28	Sanofi-Aventis Deutschland GmbH	Sanofi-Aventis Deutschland GmbH	Certificate Issued	2015-01-22	view
JXSL0900003	谷赖胰岛素注射液	insulin glulisine	Injection	Biological Products	Import Drug Application	2009-02-18	Sanofi-Aventis Deutschland GmbH	Sanofi-Aventis Deutschland GmbH	Certificate Issued	2009-12-29	view
JYSB1700214	谷赖胰岛素注射液	insulin glulisine	Injection	Biological Products	Supplementary Application	2017-12-28	Sanofi-Aventis Deutschland GmbH	Sanofi-Aventis Deutschland GmbH	Certificate Issued	2018-12-25	view
JYSB1400044	谷赖胰岛素注射液	insulin glulisine	Injection	Biological Products	Supplementary Application	2014-03-18	Sanofi-Aventis Deutschland GmbH	Sanofi-Aventis Deutschland GmbH	Certificate Issued	2014-08-27	view
JXSS0900002	谷赖胰岛素注射液	insulin glulisine	Injection	Biological Products	Import Drug Application	2009-02-06	Sanofi-Aventis Deutschland GmbH	Sanofi-Aventis Deutschland GmbH	Certificate Issued	2010-03-11	view
JYSB2100066	谷赖胰岛素注射液	insulin glulisine	Injection	Biological Products	Supplementary Application	2021-03-10	Sanofi-Aventis Deutschland GmbH	Sanofi-Aventis Deutschland GmbH	In Review	2021-03-10	view
JYSZ1900019	谷赖胰岛素注射液	insulin glulisine	Injection	Biological Products	License Renew	2019-05-20	Sanofi-Aventis Deutschland GmbH	Sanofi-Aventis Deutschland GmbH	Certificate Issued	2019-10-28	view
JYSB1300246	谷赖胰岛素注射液	insulin glulisine	Injection	Biological Products	Supplementary Application	2013-10-28	Sanofi-Aventis Deutschland GmbH	Sanofi-Aventis Deutschland GmbH	Certificate Issued	2015-01-22	view